Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or ...

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...

She has resigned from the former; the latter does not matter since 23andMe’s equity could be wiped out. If persistence pays off, a company that started out as little more than an intriguing idea and a ...

Endo + Mallinckrodt Pharmaceuticals! The ~$7B deal will "create a larger and more diversified entity with the scale and resources needed to unlock the full potential of both companies ...

We are excited to share that Mallinckrodt has entered into an agreement to combine with Endo to create a global, scaled, diversified pharmaceuticals leader. This exciting combination brings ...

Celtic manager Brendan Rodgers plans to raid Liverpool for Wataru Endo, with a journalist revealing the names of four other clubs that are keen on a summer deal for the Japan international midfielder.

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given ...

Wataru Endo has had a quiet second season at Liverpool, with the Japanese international hardly getting a look in under Arne Slot. The 32-year-old midfielder joined the Reds last season from VfB ...